Comparative Evaluation of Bacterial Diversity and Richness in CF Lung in Patients Who Use Cycled Every Other Month Tobramycin Inhalation Powder (TOBI Podhaler) Or Continuous Alternating Therapy With Tobramycin Inhalation Powder (TOBI Podhaler) and Inhaled Colistimethate
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2018
Price : $35 *
At a glance
- Drugs Tobramycin (Primary) ; Colistimethate sodium
- Indications Cystic fibrosis-associated respiratory tract infections
- Focus Therapeutic Use
- 01 Aug 2016 Status changed from active, no longer recruiting to discontinued.
- 28 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Jul 2014 New trial record